R&D-Pipeline

Bioskinco's wound dressings help severly damaged skin to achieve fast tissue regeneration and become functional again.

R&D Programs

A new product, BioCare, is in development according to European standards, based on epifast®.
epifast®, approved as medical device in Mexico by BioSkinco S.A. de C.V., is used for temporary wound coverage and as a skin substitute for severely damaged skin in Mexico. It is composed of a layer of in vitro-cultivated allogeneic human keratinocytes derived from juvenile foreskin, which is placed on a petroleum jelly gauze, is cryopreserved and stored in a frozen state for later clinical use.